Canaccord Genuity Downgrades Intersect ENT (XENT) to Hold Following Takeover Aug 6, 2021 10:23AM
Intersect ENT (XENT) PT Raised to $29 at Canaccord Genuity Jan 25, 2021 08:28AM
Canaccord Genuity Upgrades Intersect ENT (XENT) to Buy Jan 11, 2021 04:54AM
Intersect ENT to Participate at Upcoming Investor Conferences Nov 5, 2020 04:05PM
Intersect ENT (XENT) PT Lowered to $30 at Canaccord Genuity Aug 2, 2019 07:55AM


Feb 26, 2019 07:32AM Intersect ENT (XENT) PT Raised to $40 at Canaccord Genuity; Sees Improving Commercial Momentum in 2019
May 2, 2018 01:39AM Intersect ENT (XENT) PT Raised to $46 at Canaccord Genuity
Nov 3, 2016 04:05PM Intersect ENT to Present at the Canaccord Genuity Medical Technology & Diagnostics Forum
Nov 2, 2015 04:05PM Intersect ENT to Present at the Canaccord Genuity Medical Technology & Diagnostics Forum
Jul 23, 2015 04:05PM Intersect ENT to Present at the Wedbush PacGrow Life Sciences and Canaccord Genuity Conferences
Jun 29, 2015 04:12PM UPDATE: Cantor Fitzgerald Starts Intersect ENT (XENT) at Buy
Jun 8, 2015 04:01PM Intersect ENT Announces Exercise of Underwriters’ Option and the Closing of Its Public Offering
Jun 3, 2015 11:29AM Intersect ENT (XENT) Prices Larger 3.58M Common Offering at $25/Share
Jun 2, 2015 09:07PM Intersect ENT Announces Upsizing and Pricing of Public Offering
Jun 1, 2015 04:04PM Intersect ENT (XENT) Commences 3M Common Stock Offering
Jun 1, 2015 04:01PM Intersect ENT Commences Public Offering
May 20, 2015 06:07PM Intersect ENT Files S-1 Registration Statement for Proposed Public Offering
Mar 16, 2015 07:56AM Canaccord Genuity Starts Intersect ENT (XENT) at Buy
Nov 11, 2014 04:29PM Intersect ENT to Present at Canaccord Genuity and Piper Jaffray Conferences